By Drug Target Review2025-07-07T13:30:05
Shift Bioscience has published a new study introducing enhanced metrics and baselines for evaluating virtual cell models - boosting gene target discovery and accelerating its rejuvenation therapeutics pipeline.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2023-03-20T13:41:33
Sponsored by Bio-Techne
2023-09-27T13:56:39
Sponsored by Euretos
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2025-05-14T14:30:00
Sponsored by Abzena
2023-02-02T11:05:15
Sponsored by Cell Signaling Technology
2024-02-07T14:34:33
Sponsored by BellBrook Labs
Site powered by Webvision Cloud